Previous Close | 455.60 |
Open | 460.20 |
Bid | 471.40 x 0 |
Ask | 472.60 x 0 |
Day's Range | 460.20 - 460.20 |
52 Week Range | 368.00 - 532.00 |
Volume | |
Avg. Volume | 0 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IDEXX's (IDXX) new Catalyst Pancreatic Lipase Test is likely to support veterinarians globally in diagnosing pancreatitis.
Today we're going to take a look at the well-established IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's stock...